Stock ZYDUSLIFE ZYDUS LIFESCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Zydus Lifesciences Limited

Equities

ZYDUSLIFE

INE010B01027

Market Closed - NSE India S.E.
Other stock markets
 05:13:54 31/05/2024 pm IST 		5-day change 1st Jan Change
1,000 INR -2.32% Intraday chart for Zydus Lifesciences Limited -7.05% +45.12%
30/05 India's pharma export sales to grow faster this year, trade body says RE
27/05 Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research RE

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
India's pharma export sales to grow faster this year, trade body says
RE
Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research
RE
Zydus Completes Patient Enrolment for Phase II Clinical Trial of Usnoflast in ALS Patients
MT
Zydus Lifesciences Limited Announces Completion of Enrolment for Phase II Clinical Trial of Usnoflast, Novel Oral Nlrp3 Inflammasome Inhibitor in Patients with Amyotrophic Lateral Sclerosis
CI
Zydus Lifesciences Limited Receives Final Approval from USFDA for Theophylline Extended-Release Tablets, 300 Mg and 450 Mg
CI
Nomura Downgrades Zydus Lifesciences to Neutral From Buy, Adjusts Price Target to INR1,020 From INR988
MT
Zydus Lifesciences Records Sharp Rise in Fiscal Q4 Consolidated Profit
MT
Jefferies Adjusts Zydus Lifesciences' Price Target to INR1,070 From INR750, Keeps at Hold
MT
Transcript : Zydus Lifesciences Limited, Q4 2024 Earnings Call, May 17, 2024
Zydus Lifesciences Limited Proposes Final Dividend for the Financial Year Ended on March 31, 2024, Payable on or After August 13, 2024
CI
Zydus Lifesciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Zydus Lifesciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
CI
Zydus Lifesciences Gets US FDA Nod to Market Dexamethasone Tablets
MT
India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says
RE
Zydus Lifesciences Limited Announces Completion of Enrolment for EPICS IIITM Phase 2B/3 Trial Evaluating Saroglitazar Mg in Treatment of Primary Biliary Cholangitis
CI
Zydus Lifesciences Gets US FDA Final Nod for Acne Treatment Gel
MT
Zydus Lifesciences Limited Receives Final Approval from USFDA for Dapsone Gel, 7.5%
CI
Sentynl Therapeutics Announces Global Acquisition of Zokinvy for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals
AQ
Zydus Lifesciences Arm Acquires Eiger BioPharmaceuticals' Progeria Drug
MT
Bayer Pharmaceuticals Pvt. Ltd. agreed to acquire the 24.99998% stake in Bayer Zydus Pharma Private Limited for INR 2.82 billion.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ZYDUSLIFE Stock
  4. News Zydus Lifesciences Limited